They Knew Lipid Nanoparticles Didn’t Stay in the Inject Site

Australian Vaccine Biodistribution Data

This is one of the most disturbing videos I have ever seen.

It confirms that the TGA knew back in Jan 2021 that the lipid nanoparticles (and the mRNA) didn’t stay in the inject site, but spread throughout the entire body including the brain, the liver and female ovaries.

This should have raised red flags everywhere, especially when there was zero data of what the medium & long term adverse effects that this would cause.

Yet the TGA allowed these experimental injections to be approved with the intention that that substance would injected into every Australian – and the TGA KEPT QUIET about the fact that mRNA would spread through the entire body.

This destroyed the concept of “informed consent”.

THE AUSTRALIAN FEDERAL POLICE should be down at the TGA this morning seizing their computers and phones and taking people into custody.

No wonder the TGA desperately tried to prevent this document being released under Freedom of Information.

Video Chapters
0:00 Introduction
1:00 Redacted Data
2:20 Lipid Nanoparticles
9:20 Data
12:55 Metabolism

24th March 2023 (sorry)

Tissue distribution (lipid nanoparticles encapsulation RNA)

(Page 44)

Rats after i.m. vaccine injection

The concentration of radioactive lipid marker reached the peak level in plasma (8.9 μg lipid eqv/mL),

between 1 – 4 h post-dose,

and distribution mainly into liver, adrenal glands, spleen and ovaries over 48 h

Concentrations were higher in plasma than in blood, with mean blood: plasma ratios of 0.5 – 0.6.

DISTRIBUTION (page 40)

The distribution of LNP-BNT162b2 (V9) mRNA or expressed S protein was not studied.

Table 4-2. Mean concentration of radioactivity (sexes combined) in tissue and blood following a single IM dose of 50 μg mRNA/rat

(page 45)

Mean total radioactivity was greatest at the injection site followed by the liver,

with much lower total recovery in spleen, adrenal glands and ovaries

The tissue distribution pattern was similar in 100 μg mRNA/animal dose group as noted above for 50 μg mRNA/animal dose,

with highest distribution into liver, adrenal glands and spleen.

Conclusions

Slow but significant distribution of lipid nanoparticles from the site of injection with major uptake into liver.

Minor distribution in spleen, adrenal glands and ovaries over 48 h.

Mean blood:plasma ratios of 0.5-0.6 indicating nanoparticles mainly present in plasma fraction of blood with peak concentrations in plasma at approx. 2 h post-dose.

Liver concentrations over time

25 mins 0.74

1 hour 4.62

2 hours 10.97

4 hours 16.55

8 hours 26.54

24 hours 19.24

48 hours 24.29

METABOLISM

(page 46)

In vitro studies indicated minor metabolism of ALC-0159 and ALC-0315 in liver, with most of the lipids found unchanged at the end of the 2 or 4 h incubation period.

Nonclinical Evaluation Report TGA Health Safety Regulation